1. Introduction {#s0005}
===============

Impulsivity is defined as a predisposition toward rapid and unplanned actions without regard to their negative consequences. It is classically divided in two main dimensions: motor and choice impulsivity, the former related with the incapacity to suppress actions and the latter reflecting delay intolerance, characterized, for instance, as a preference for small but immediate instead of larger but delayed rewards ([@b0010], [@b0045]). Impulsivity can be advantageous in competitive environments, where riskier and quicker actions can result in positive outcomes. However, impulsivity can be maladaptive, manifesting in conditions such as attention deficit and hyperactivity disorder (ADHD), addiction and substance abuse ([@b0055], [@b0185], [@b0210]) and even in neurodegenerative disorders ([@b0095]). On the other hand, evidence suggests that trait impulsivity is a predisposing factor for the development of maladaptive behaviors -- see for instance ([@b0060]).

Around 10% of chronic pain patients develop addictive behaviors and are highly predisposed to opioid misuse ([@b0245]). However, little is known about the relationship between impulsivity and chronic pain. Some studies indicate that chronic pain patients and healthy subjects present similar scores in the Barret Impulsivity Scale (BIS) ([@b0020], [@b0160]). Similarly, no differences were observed in the Go/No-Go and Stroop tasks ([@b0090], [@b0120], [@b0195], [@b0235]). On the other hand, chronic pain patients with comorbid opioid misuse score higher on BIS than chronic pain patients without this problem ([@b0160], [@b0165], [@b0225]). Additionally, urgency and sensation-seeking dimensions of the urgency, premeditation, perseverance and sensation-seeking (UPPS) impulsivity scale can predict this misuse ([@b0240]), suggesting an importance of trait impulsivity on analgesic-related addiction.

In rodent models of chronic pain, data is scarce and conflicting -- contrast for instance ([@b0180], [@b0135], [@b0110]). Recently, we have analyzed a large cohort of rats in the variable delay-to-signal (VDS) and found a high variability in trait impulsivity related with sex, age and even strain ([@b0215]). Considering the conflicting results in chronic pain conditions and the heterogeneity observed in outbred animals, we hypothesized that baseline impulsivity can influence the impact of chronic pain on impulsive behavior. For that we first compared impulsive behavior of controls and neuropathic rats on the VDS paradigm. Next, we evaluate the impact of the neuropathic lesion on animals with high and low levels of impulsivity at the baseline. We show that the neuropathy exacerbates impulsivity in animals that present high trait impulsivity at baseline.

2. Materials and methods {#s0010}
========================

2.1. Experimental design {#s0015}
------------------------

Two independent experiments were performed in this study ([Fig. 1](#f0005){ref-type="fig"}A). In the first experiment we studied the impact of chronic pain on impulsivity. For that, a group of rats performed the VDS paradigm 4 weeks after the spared nerve injury (SNI) or the Sham surgery. In the second experiment, we studied the influence of baseline impulsivity on chronic pain-related impulsivity. For that, a group of naïve rats was divided in high (HI) and low impulsive (LI) according to their performance in the VDS (VDS I). Then, SNI was performed in 2/3 of the animals from each group and Sham surgery on the other 1/3. 6 weeks after the surgery, animals were tested again in the VDS paradigm (VDS II).Fig. 1Experimental Design. Experimental design for experiments 1 and 2 (A). Weight evolution of Sham and SNI was similar in experiment 1 (B) and 2 (D); average difference between groups was at its maximum \<4% of controls' weight. SNI animals present increased allodynia to the Von Frey monofilaments in comparison to controls in experiment 1 (C) and 2 (E). Data presented as mean ± SEM. \*\*\* p \< 0.001. FR -- Food restriction; HI -- High impulsive; LI -- Low Impulsive; SNI -- Spared Nerve Injury; VDS -- Variable delay-to-signal.

2.2. Experimental subjects {#s0020}
--------------------------

All procedures were approved by the Portuguese National Authority for Animal Health (Direção Geral de Alimentação e Veterinária -- DGAV) and in accordance with the guidelines of the European Communities Council Directive 2010/63/EU. Efforts were made to ensure the well-being of the animals used. Sixty (30 + 30) male Wistar-Han rats with 7 weeks of age at the beginning of the experiments were used. Animals were kept in Specific Pathogen Free (SPF) conditions, in a room with controlled temperature (22 °C ± 1 °C) and humidity (50--60%) under a 12 h light/dark cycle (lights on at 8 am), and randomly housed in pairs in plastic cages with food (4RF21; Mucedola, SRL, Settimo Milanese, Italy) and water available *ad libitum*, except during the VDS protocol, in which food availability was restricted to 1 h/day. Weight was controlled along the entire experiment time course, particularly during the food restriction period to prevent drops below 15% of baseline values.

2.3. Variable delay-to-signal {#s0025}
-----------------------------

The VDS was performed in 5-hole operant chambers (25 × 25 cm; TSE Systems, Germany) as previously described ([@b0145]). Briefly, the VDS test comprised 3 phases: habituation to the chamber and rewards (4 days), training, and VDS test. The training consisted of 10 sessions (1 per day) with a maximum of 100 trials or 30 min each. Animals which repeated the VDS, performed only 6 sessions of training in the VDS II. Trials started with the lightning of the house light for 3 s (delay period) followed by the light stimulus (3 W) in the response aperture (central hole) for 60 s (response period). Nosepokes during the response period were rewarded with the delivery of a sugar pellet (45 mg, Bioserv Inc., New Jersey, EUA). Omissions and responses in the delay period (premature responses) were punished with a timeout in complete darkness (3 s) and no reward. The order in which animals performed the training was changed along the days to exclude timing effects. The test session was composed by 120 trials similar to training. This session started with an initial block of 25 trials with 3 s-delay trials (3s~i~) followed by 70 trials of 6- and 12-seconds delays (6 s and 12 s, respectively) presented in a random order. The VDS test session terminated with a final block with 25 trials of 3 s delays (3s~f~). In the test, premature responses were registered but not punished.

Motor impulsivity was evaluated by the number of premature responses along training, while choice impulsivity was evaluated by the number of premature responses in the test during and after the exposure to 6 s and 12 s delays (delay intolerance). Prematurity rate (PR) was defined as the number of premature responses per time of available delay and PR~ratio~ as the PR corrected for baseline responsiveness (3s~i~):$$\mathit{PR}_{\mathit{ratio}} = log\frac{{PR6s/12s/3s}_{f}}{{PR3s}_{i}}$$

2.4. Spared nerve injury {#s0030}
------------------------

Chronic neuropathic pain was induced using the SNI ([@b0065]). Rats were anesthetized via intraperitoneal administration of 1:1.5 mix (1 ml/kg) of Sededorm® (Medetomidine, 1 mg/mL -- VetPharma Animal Health, Spain) and Ketamidor® (Ketamine, 100 mg/mL -- Richter Pharma AG, Austria), respectively ([@b0080]). A blunt incision was then performed to expose the three branches of sciatic nerve: common peroneal, tibial and sural nerves. A unilateral ligation and subsequent distal axotomy of the tibial and common peroneal nerves were then performed, leaving the sural nerve (spared nerve) intact. In Sham animals all the nerves were exposed but left intact. Anaesthesia was reversed with a subcutaneous injection of Antisedan® (Atipamezole Hydrochloride, ORION Corporation, Finland). In both experiments, 10 animals were used as Sham controls and 20 as SNI, 10 lesioned in the left (SNI-L) and 10 in the right hindpaw (SNI-R). In the second experiment, animals were ranked by their PR~ratio~ in VDS I and distributed according to the following sequence: Sham, SNI-L, SNI-R, SNI-R, SNI-L, Sham. After SNI, animals were left to recover in their cages and monitored for open wounds and signs of inflammation. No major problems were observed in the study.

2.5. Mechanical allodynia {#s0035}
-------------------------

Mechanical allodynia was assessed as previously described ([@b0100]) using the up-and-down method ([@b0040]). Briefly, Von Frey monofilaments of different forces were used: 15.0 g, 8.0 g, 6.0 g, 4.0 g, 2.0 g, 1.0 g, 0.6 g and 0.4 g (North Coast Medical Inc., USA). Each measure started with the central filament (2.0 g) and advanced upward if no response was elicited or downward if a brisk paw withdrawn was observed, until 6 measures around the turning point were obtained or the limits of the scale were reached. 50% threshold was then calculated using the formula$$50\% g\_ threshold = \frac{(10^{\mathit{Xf} + K.\delta})}{10000}$$where X~f~ = value (in log units) of the final von Frey filament; k = tabular value corresponding to pattern of positive and negative responses; δ = mean difference (in log units) between stimuli (0.224).

2.6. Statistics {#s0040}
---------------

Statistical analysis was done in the JASP 0.9.2 software (JASP Team (2019), Netherlands) and graphs were obtained through GraphPad PRISM 8.0 software (GraphPad software, Inc., USA). In the second experiment, 2 animals (1 Sham HI and 1 Sham LI) were excluded from the VDS test analysis because they were considered extreme outliers according to Tukey's criterion (higher than Q3 + 3(Q3 -- Q1), being Q1 and Q3, 1st and 3rd quartile, respectively) in the 6 s and in the 3s~i~ and 3s~f~ intervals, respectively. Repeated measures ANOVA was used to analyze body weight, VDS training, VDS test and re-test effects. Independent t-tests were used to compare SNI and Sham allodynia and PR or its ratios, at the different intervals, whenever a difference between the groups was revealed in the ANOVA. Mauchly's test was used to evaluate sphericity, and Levene's test to evaluate equality of variances. The Greenhouse-Geisser and the Welch corrections were used when sphericity and equality of variances were rejected, respectively. Bonferroni was used as post-hoc test. Cohens' d (*d*) and eta square(ɳ^2^) were used as effect size measures in t-tests and ANOVA's, respectively. Data was considered significant if p \< 0.05. All results are represented as mean ± SEM.

3. Results {#s0045}
==========

3.1. Body weight and mechanical allodynia {#s0050}
-----------------------------------------

Body weight was controlled frequently to ensure animals' well-being and to regulate weight loss during food restriction. None of the animals lost more than 15% of its initial weight. In the first experiment, SNI rats were more affected by the surgery and weight gain remain below the levels of controls throughout the experiment (F~(1,\ 28)~ = 21.61, p \> 0.001, ɳ^2^ = 0.436) ([Fig. 1](#f0005){ref-type="fig"}B). Importantly, after the first week, the weight evolution was identical between the 2 groups (F~(1,\ 28)~ = 2.045, p = 0.164, ɳ^2^ = 0.068) and, at its maximum, average weight difference between the two groups was \<4% of controls weight. In the second experiment, no differences between the groups were found (Lesion: F~(1,\ 28)~ = 2.438, p = 0.130, ɳ^2^ = 0.080; Lesion\*Time: F~(1.976,\ 55.340)~ = 1.290, p = 0.283, ɳ^2^ = 0.002) ([Fig. 1](#f0005){ref-type="fig"}D).

As expected, SNI animals developed mechanical allodynia after the installation of the model in the first (t~(28)~ = −12.678, p \> 0.001, *d* = −4.910) ([Fig. 1](#f0005){ref-type="fig"}C) and second experiment (t~(19)~ = 18.52, p \> 0.001, *d* = −5.026) ([Fig. 1](#f0005){ref-type="fig"}E).

3.2. Experiment 1 -- chronic pain does not affect impulsivity {#s0055}
-------------------------------------------------------------

The potential impact of chronic pain on impulsivity was accessed using the VDS test ([Fig. 1](#f0005){ref-type="fig"}A, Experiment 1).

All animals learned the task equally (Lesion: F~(1,\ 28)~ \< 0.001, p \> 0.999, ɳ^2^ \< 0.001; Lesion\*Time: F~(9,\ 252)~ = 0.097, p \> 0.999, ɳ^2^ = 0.001) ([Fig. 2](#f0010){ref-type="fig"}A) as observed by the evolution of the timed responses. Also, no significant differences between groups were observed in the number of premature responses throughout training (Lesion: F~(1,\ 28)~ = 3.654, p = 0.066, ɳ^2^ = 0.115; Lesion\*Time: F~(3.606,\ 100.978)~ = 0.646, p = 0.615, ɳ^2^ = 0.007) ([Fig. 2](#f0010){ref-type="fig"}B) or in the test sessions (PR -- Lesion: F~(1,\ 28)~ = 0.193, p = 0.064, ɳ^2^ = 0.007; Lesion\*Time: F~(1.400,\ 39.203)~ = 0.643, p = 0.478, ɳ^2^ = 0.010; PR~ratio~ -- Lesion: F~(1,\ 27)~ = 0.046, p = 0.831, ɳ^2^ = 0.002; Lesion \* Time: F~(1.374,\ 37.104)~ = 1.103, p = 0.322, ɳ^2^ = 0.005) ([Fig. 2](#f0010){ref-type="fig"}C-D).Fig. 2Experiment 1: impact of chronic pain on impulsive behavior. Both groups learned the task equally (A) and no differences on impulsive behavior were found between the groups during VDS training (B) nor test (C, D). Data presented as mean ± SEM. 3s~i~ -- initial trials with 3 s' delay; 6 s -- trials with 6 s' delay; 12 s -- trials with 12 s' delay; 3s~f~ -- final trials with 3 s' delay; PR -- Prematurity rate; SNI -- Spared Nerve Injury; VDS -- Variable delay-to-signal.

3.3. Experiment 2 {#s0060}
-----------------

### 3.3.1. VDS I -- determination of baseline impulsivity {#s0065}

To test for potential effects of baseline impulsivity, we evaluated, in a second experiment, impulsive behavior before pain onset ([Fig. 1](#f0005){ref-type="fig"}A, Experiment 2). The group presented high heterogeneity regarding PR and PR~ratio~ on the 3s~f~ of the VDS test ([Fig. 3](#f0015){ref-type="fig"}A-B). Based on the 3s~f~ PR~ratio~ animals were divided in two groups: half were considered HI and half LI ([Fig. 3](#f0015){ref-type="fig"}B). 2/3 of each group were ascribed to SNI surgery while the remaining 1/3 to Sham surgery. In a retrospective analysis accounting for the newly formed groups, no differences were observed in the learning curves for LI vs HI comparisons (F~(1,\ 28)~ = 0.439, p = 0.513, ɳ^2^ = 0.015) ([Fig. 3](#f0015){ref-type="fig"}C) and Sham vs SNI comparisons (F~(1,\ 28)~ = 1.341, p = 0.257, ɳ^2^ = 0.046) ([Fig. 3](#f0015){ref-type="fig"}E). Expectedly, HI presented a significantly higher PR~ratio~ than LI in all phases of the VDS test (F~(1,\ 28)~ = 19.09, p \< 0.001, ɳ^2^ = 0.450; 6 s: t~(28)~ = 2.706, p = 0.011, *d* = 0.988; 12 s: t~(28)~ = 2.454, p = 0.021, *d* = 0.896; 3sf: t~(28)~ = 5.387, p \< 0.001, *d* = 1.967) ([Fig. 3](#f0015){ref-type="fig"}D). No differences were however found between the animals ascribed to be Sham or SNI (F~(1,\ 28)~ = 0.031, p = 0.861, ɳ^2^ = 0.001) ([Fig. 3](#f0015){ref-type="fig"}F).Fig. 3Experiment 2, VDS I: determination of baseline impulsivity. Naïve rats show different levels of impulsivity in the VDS test (A). Based on the 3s~f~ PR~ratio~ (B), animals were divided in half in HI and LI. HI rats are more impulsive on the test (D) but not during training (C). Rats selected for SNI or Sham surgeries, presented similar impulsive behavior (E, F). Data presented as mean ± SEM. \* p \< 0.05 \*\*\* p \< 0.001. 3s~i~ -- initial trials with 3 s' delay; 6 s -- trials with 6 s' delay; 12 s -- trials with 12 s' delay; 3s~f~ -- final trials with 3 s' delay; HI -- High impulsive; LI -- Low Impulsive; PR -- Prematurity rate; SNI- Spared Nerve Injury; VDS -- Variable delay-to-signal.

### 3.3.2. VDS II -- CP effects on impulsivity are dependent on the baseline {#s0070}

After the definition of the groups, HI and LI (3.2.1), SNI surgery was performed. At 6 weeks post-surgery, animals performed 6 VDS training sessions, presenting a moderate reduction on premature responses and consequently an increase in the number of timed responses, in comparison with rats of the same groups from experiment 1 (Timed responses -- Sham: F~(2,\ 17)~ = 7.398, p = 0.005, ɳ^2^ = 0.465; Exp 1 vs HI: t = −3.453, p = 0.009, *d* = −0.772; Exp 1 vs LI: t = −2.749, p = 0.041, *d* = −0.615; HI vs LI: t = 0.610, p \> 0.999, *d* = 0.137 ([Fig. 4](#f0020){ref-type="fig"}A); SNI: F~(2,\ 37)~ = 8.450, p \< 0.001, ɳ^2^ = 0.314; Exp 1 vs HI: t = −3.062, p = 0.012, *d* = −0.484; Exp 1 vs LI: t = −3.607, p = 0.003, *d* = −0.570; HI vs LI: t = −0.471, p \> 0.999, *d* = −0.075 ([Fig. 4](#f0020){ref-type="fig"}B); Premature responses -- Sham: F~(2,\ 17)~ = 7.391, p = 0.005, ɳ^2^ = 0.465; Exp 1 vs HI: t = 3.411, p = 0.010, *d* = 0.763; Exp 1 vs LI: t = 2.810, p = 0.036, *d* = 0.628; HI vs LI: t = −0.520, p \> 0.999, *d* = −0.116 ([Fig. 4](#f0020){ref-type="fig"}C); SNI: F~(2,\ 37)~ = 8.500, p \< 0.001, ɳ^2^ = 0.315; Exp 1 vs HI: t = 3.171, p = 0.009, *d* = 0.501; Exp 1 vs LI: t = 3.542, p = 0.003, *d* = 0.560; HI vs LI: t = 0.321, p \> 0.999, *d* = 0.051 ([Fig. 4](#f0020){ref-type="fig"}D)), possibly reflecting a learning and/or re-test effect. Importantly, all groups presented no differences in timed (Group: F~(3,\ 26)~ = 0.117, p = 0.949, ɳ^2^ = 0.013; Group\*Time: F~(10.437,\ 90.458)~ = 1.557, p = 0.129, ɳ^2^ = 0.063) or premature responses (Group: F~(3,\ 26)~ = 0.168, p = 0.917, ɳ^2^ = 0.019). A group\*time interaction was observed in the premature responses (F~(11.802,\ 102.284)~ = 2.711, p = 0.003, ɳ^2^ = 0.083) but post-hoc tests did not reveal any differences between the groups.Fig. 4Re-test effects. Both Sham and SNI increased the number of timed responses (A, B) and decrease prematurity levels (C, D) when compared with the same groups from experiment 1. No differences were found in the number of timed and premature responses between the four groups. HI -- High impulsive; LI -- Low Impulsive; SNI -- Spared Nerve Injury.

In the VDS test, SNI animals showed a tendency to perform more premature responses than Sham (PR: F~(1,26)~ = 3.887, p = 0.059, ɳ^2^ = 0.130) ([Supplementary data](#s0095){ref-type="sec"}, [Fig. 1](#f0005){ref-type="fig"}). Considering trait impulsivity in these animals, we observed that while LI animals were not affected by SNI (PR: F~(1,12)~ = 0.584, p = 0.459, ɳ^2^ = 0.046; PR~ratio~: F~(1,13)~ = 0.344, p = 0.568, ɳ^2^ = 0.026) ([Fig. 5](#f0025){ref-type="fig"}A, C), HI SNI rats were more impulsive than the corresponding Sham controls on the 3s~f,~ (PR: F~(1,12)~ = 4.928, p = 0.046, ɳ^2^ = 0.291; 3s~i~: t~(12)~ = 1.671, p = 0.121, *d* = 0.988; 6 ~s~: t~(12)~ = 0.827, p = 0.424, *d* = 0.489; 12 ~s~: t~(12)~ = 0.884, p = 0.394, *d* = 0.523; 3s~f~: t~(12)~ = 2.951, p = 0.012, *d* = 1.746) ([Fig. 5](#f0025){ref-type="fig"}B). These results show that only animals that are more impulsive at the baseline are affected after a neuropathic lesion. Interestingly, differences between Sham and SNI in the PR on the 3s~f~ trials are mainly dependent of SNI-L (F~(2,11)~ = 4.027, p = 0.049, ɳ^2^ = 0.423; Sham vs SNI-L: t = −2.824, p = 0.050, *d* = −0.755) ([Fig. 5](#f0025){ref-type="fig"}D inset; [supplementary data](#s0095){ref-type="sec"}, [Fig. 2](#f0010){ref-type="fig"}). No effects were seen in the PR~ratio~ (F~(1,13)~ = 0.073, p = 0.792, ɳ^2^ = 0.006) ([Fig. 5](#f0025){ref-type="fig"}D). However, comparing the evolution of PR~ratio~ from VDS I to VDS II in all groups, only SNI-L LI and HI are different between each other (F~(5,24)~ = 3.644, p = 0.014, ɳ^2^ = 0.432; SNI-L HI vs SNI-L LI: t = 3.474, p = 0.029, *d* = 0.634) ([Fig. 5](#f0025){ref-type="fig"}E). It appears that while Sham and SNI-R animals corrected their impulsivity levels in the second VDS, SNI-L animals maintained them ([Fig. 5](#f0025){ref-type="fig"}E).Fig. 5Experiment 2, VDS II: Effect of chronic pain on HI and LI animals. HI rats with chronic pain, mainly SNI-L, are more impulsive than the corresponding controls in the PR (B) although not in the PR~ratio~ (D). LI animals are not affected (A, C). Sham and SNI-R animals corrected the levels of impulsivity from VDS I to VDS II, but in SNI-L, HI and LI maintained their PR~ratio~ (E). Data presented as mean ± SEM. \* p \< 0.05, \*\* p \< 0.01. 3s~i~ -- initial trials with 3 s' delay; 6 s -- trials with 6 s' delay; 12 s -- trials with 12 s' delay; 3s~f~ -- final trials with 3 s' delay; HI -- High impulsive; L -- left; LI -- Low Impulsive; PR -- Prematurity rate; R -- right; SNI -- Spared Nerve Injury; VDS -- Variable delay-to-signal.

4. Discussion {#s0075}
=============

In this work we studied SNI impact on impulsive behavior in an heterogeneous population of outbred rats (experiment 1) and in a previously characterized population regarding trait impulsivity (experiment 2). We observed no differences between lesioned and control groups in any aspect of impulsive behavior. When considering impulsivity baseline, HI SNI animals were more intolerant to delay than the respective controls while LI were not affected by the neuropathy. Also, while Sham animals adjusted their behavior between the 2 VDS assessments, SNI animals failed to do so.

Results reported here are in line with a previous study of the group in which at the 3s~f~ VDS block Sham and SNI behaved similarly ([@b0135]), even though in that report SNI-R presented a higher PR~ratio~ during the longest delay trials that was not observed here. Results shown here are also in accordance with the work from Higgins and colleagues that tested SNI animals in the 5-choice serial reaction time task (5-csrtt) which bears some resemblance with the VDS training protocol ([@b0110]). On the contrary, Pais-Vieira and colleagues reported a decrease in impulsivity on the 5-csrtt ([@b0180]), in a monoarthritic inflammatory model of chronic pain, initiated in the day after chronic pain induction, suggesting some specificity regarding the type or duration of pain.

VDS II revealed, in the training, a re-test effect characterized by an increase in the number of timed responses and a decrease in motor impulsivity. Importantly, this effect was observed independently of lesion and trait impulsivity. In the test, HI SNI animals (mainly left-lesioned) were more intolerant to delay than the respective controls and when VDS I and VDS II were compared, we observed that both LI and HI Sham and SNI-R adjusted their behavior but not SNI-L. This maintenance of impulsivity levels might result from a complex interaction of re-test and/or learning effects.

Trait impulsivity differences manifest in other behavioral domains ([@b0105]). For instance, it has been observed that HI animals perform worse in working memory tasks ([@b0115], [@b0200]) and present increased anxiety-like behavior([@b0220]) though some conflicting evidence has also been reported ([@b0230]). Furthermore, HI predicts nicotine and cocaine self-administration ([@b0005], [@b0050], [@b0075], [@b0190]) and increases seeking behavior for sucrose and palatable food ([@b0070], [@b0230]).

Transcriptional differences between HI and LI rats have been found in the Nucleus Accumbens (NAc), ventral tegmental area, dorsomedial striatum and orbitofrontal cortex at basal conditions ([@b0025], [@b0035], [@b0175]). In the NAc, HI animals present a decreased availability of D1 and D2/3 receptors and of dopamine transporter (DAT) ([@b0030], [@b0125]) as well as a reduction in grey matter density ([@b0035]). Interestingly, deep brain stimulation in the NAc decreases impulsivity particularly in HI animals ([@b0205]). The NAc has been involved in chronic pain -- see for review ([@b0015], [@b0170]) -- and appears as a prime candidate to mediate decision-making and motivational alterations observed in chronic pain models. Moreover, it has been described in HI rats a reduction of gray matter density as well as a reduction of D2/3 receptor, glutamate decarboxylase (GAD)~65/67~, microtubule-associated protein 2 (MAP2) and spinophilin in the left (but not right) NAc ([@b0030], [@b0035]) which might explain some of the lateralized effects observed in animal models of chronic pain. Indeed, in this and in previous works from the group we observed lesion-side specific impairments on behavior, namely increased anxious-like behavior in SNI-L and cognitive flexibility deficits in SNI-R ([@b0140], [@b0135]). Interestingly, lateralized effects of chronic pain have also been observed in chronic pain patients ([@b0085]).

In conclusion, chronic pain preclinical models manifest comorbid behaviors such as depressive- and anxiety-like behaviors, and cognitive deficits ([@b0150], [@b0155], [@b0250]). These have been shown to depend on a number of factors including experimental subject age ([@b0130]), pain duration ([@b0255]) and injury location ([@b0140], [@b0135]). In addition, our results indicate that trait manifestations should also be considered in the complex relation between chronic pain and comorbid behaviors.
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